Found 8 matching trials
Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations PHASE2 This study is a Phase 2 trial designed to evaluate the clinical efficacy, s...
Show More Status
Active Not Recruiting
Location
Cincinnati Children's Hospital
Learn More & Join Trial
A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period PHASE2 The purpose of this study is to evaluate clinical efficacy and safety of ar...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Efficacy and Safety of MAS825 in Patients With COVID-19 PHASE2 This clinical study was designed to assess the efficacy and safety of MAS82...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Single-patient Clinical Trial of MAS825 in a Patient With XIAP Deficiency PHASE3 MAS825 is a bi-specific IgG1 monoclonal antibody that simultaneously target...
Show More Location
The Hospital for Sick Children
Learn More & Join Trial
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa PHASE2 The main purpose of this study is to assess preliminary efficacy and safety...
Show More Status
Active Not Recruiting
Location
Olympian Clinical Research
Learn More & Join Trial
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) PHASE2 This Phase 2a clinical trial evaluated the effectiveness, safety, and toler...
Show More Location
Washington University
Learn More & Join Trial
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease PHASE2 The study is a phase II trial designed to evaluate the clinical efficacy, s...
Show More Location
Cincinnati Childrens Hospital
Learn More & Join Trial
A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers PHASE1 The study is conducted to investigate the safety, tolerability and pharmaco...
Show More Location
Novartis Investigative Site
Learn More & Join Trial